Table 2.
Cardiac magnetic resonance evaluation of the participants
| LV end-diastolic volume (mL) | 153 [125–216] |
| LV end-diastolic volume index (mL/m2) | 87 [75–126] |
| LV end-systolic volume (mL) | 70 [47–125] |
| LV end-systolic volume (mL/m2) | 42 [29–73] |
| LV mass (g) | 108 [89–138] |
| LV mass index (g/m2) | 63 [53–78] |
| LVEF (%) | 53 [41–62] |
| Reduced LVEF (< 40%) | 25 (22%) |
| Presence of LV LGE, n (%) | 76 (67%) |
| LV LGE mass (g) | 6 [0–13] |
| LV LGE mass (%) | 5 [0–10] |
| Presence of LV aneurysm, n (%) | 38 (34%) |
| Apical | 35 (31%) |
| Inferolateral | 3 (3%) |
| RV end-diastolic volume (mL) | 114 [93–132] |
| RV end-diastolic volume index (mL/m2) | 46 [33–63] |
LVEF left ventricular ejection fraction, LGE late gadolinium enhancement, LV left ventricular, RV right ventricular